Patents by Inventor Henriette Schrank

Henriette Schrank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions
    Patent number: 5593686
    Abstract: The present invention provides a pharmaceutical composition for the transdermal systemic administration of an active agent characterized in that the active agent is bopindolol or methysergide. Also the present invention provides a pharmaceutical composition for the transdermal systemic administration of a pharmacologically active agent characterized in that it contains bopindolol, tizanidine, clemastine, ketotifen or methysergide as active agent in a reservoir comprising a hydrophilic polymer. Furthermore a pharmaceutical composition for the transdermal systemic administration of pharmacologically active agents characterized in that the pharmacologically active agent is in a reservoir comprising a polyacrylate polymer containing cationic ester groups.
    Type: Grant
    Filed: September 28, 1994
    Date of Patent: January 14, 1997
    Assignee: Sandoz Ltd.
    Inventors: Thomas Kissel, Henriette Schrank, Hans-Rainer Hoffmann
  • Pharmaceutical compositions
    Patent number: 5364628
    Abstract: The present invention provides a pharmaceutical composition for the transdermal systemic administration of an active agent characterized in that the active agent is bopindolol or methysergide. Also the present invention provides a pharmaceutical composition for the transdermal systemic administration of a pharmacologically active agent characterized in that it contains bopindolol, tizanidine, clemastine, ketotifen or methysergide as active agent in a reservoir comprising a hydrophilic polymer. Furthermore a pharmaceutical composition for the transdermal systemic administration of pharmacologically active agents characterised in that the pharmacologically active agent is in a reservoir comprising a polyacrylate polymer containing cationic ester groups.
    Type: Grant
    Filed: October 22, 1993
    Date of Patent: November 15, 1994
    Assignees: Sandoz Ltd., LTS Lohmann Therapie-Systeme GmbH & Co.
    Inventors: Thomas Kissel, Henriette Schrank, Hans-Rainer Hoffmann
  • Interleukin therapy
    Patent number: 4863740
    Abstract: Interleukin-2 liposomes are advantageous sustained release formulations.
    Type: Grant
    Filed: May 12, 1988
    Date of Patent: September 5, 1989
    Assignee: Sandoz Ltd.
    Inventors: Thomas Kissel, Jurg Reinhardt, Henriette Schrank